Johnsons & Johnsons voluntarily recall Tylenol.
The Food and Drug Administration (FDA) of United States has issued a statement which says that Johnsons & Johnsons have asked voluntarily for a recall of all lots of Tylenol Arthritis Pain Caplet 100 count bottles with red caps. The recall was announced after the company’s consultation with FDA.
In November 2009, consumers reported presence of unusual moldy and musty smell. The smell was linked to nausea, vomiting, diarrhea, and stomach pain. The company made a recall to 5 lots of Tylenol but later expanded it to all lots of Tylenol bottles with EZ-OPEN caps. It was discovered that the unusual moldy smell has its roots in traces of a substance called 2,4,6 – tribromoanisole which is present in the bottle caps. It is believed that the source of 2,4,6-tribromoanisole is the breakdown of a chemical which is used on wooden pallets to move packaging material from one place to other. However, FDA has mentioned that the medical effects of the substance on user’s health are not well-known and well-studied and the complaints filed to the company are ‘non-serious’. FDA has also asked the consumers who have already purchased Tylenol Arthritis Pain Caplet 100 counts EZ-Open Caps bottles from the lots which are included in the recall should avoid using the medicine. These consumers can return the bottles to McNeil for refund.
Tylenol and Johnson & Johnsons have a history of recalls. The medicine was first recalled in 1986 when an individual tampered the drugs and laced them with cyanide. Almost seven people died after the use of those drugs. Johnsons & Johnsons acted quickly and asked for a recall of Tylenol from every drug store and outlet. The company restarted the sale of Tylenol after covering it with tamper-proof packaging.



Comments